Nope still holding what i bought last week, but I am starting to get worried. We had great momentum for 2 days and seem to have lost it which has been pattern for last 2-3 years.
I will probably hold it for another month or so. If there is no action from management, i will sell.
the share price will languish once again.
i have been in this for last 3 years and that has been the history and it is one of the most frustrating stock. Sometimes it seems like management has absolutely no desire for higher stock price for whatever reason.
Even if they are making gold out of thin air.
After all this, this trades at 12X forward revenue over 200 billion dollars?
Really? its almost like BABA has infinite growth ahead.
tens of Billions!
WS = The biggest wealth transfer machine in the world!
Including that big mouth, wiesel on CNBC
They have chance to buy their own highly profitable (PE=3) business for pennies on dollars (25% of book value)
This is once in a 25 years opportunity. I hope they are not that dumb.
Otherwise it will be just 1-2 days wonder and languish like it has been for years.
Company lost over 200 million dollar market cap = money in shorts pocket
Who are these morons who keep selling? I thought it will recover after company PR but it cratered even more.
This is unprecedented.
They will aggressively start buying back stock.
There is nothing more profitable in this world than buying your own highly profitable business that at 25% of book value. Its like buying $1 for 25 cents. It is 300% return.
There is no way XIN can even dream about earning those returns no matter how bullish the China real estate market gets.
I added to my existing position on Jan 30 (bought at much higher price) and it is nothing but frustrating.
At the time I discovered this stock, I thought I was getting bargain of the decade.
This is got to be the most undervalued Biotech stock in the universe (Given the pipeline and balance sheet) but it just does not get traction beyond a couple of days.
Having said that the management of this company nothing to be desired (based on how cheaply they made Kadcyla deal)
Just a change in management will bolt this stock by 20% IMO